Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Garnett, Mathew J.
Автор Edelman, Elena J.
Автор Heidorn, Sonja J.
Автор Greenman, Chris D.
Автор Dastur, Anahita
Автор Lau, King Wai
Автор Greninger, Patricia
Автор Thompson, I. Richard
Автор Luo, Xi
Автор Soares, Jorge
Автор Liu, Qingsong
Автор Iorio, Francesco
Автор Surdez, Didier
Автор Chen, Li
Автор Milano, Randy J.
Автор Bignell, Graham R.
Автор Tam, Ah T.
Автор Davies, Helen
Автор Stevenson, Jesse A.
Автор Barthorpe, Syd
Автор Lutz, Stephen R.
Автор Kogera, Fiona
Автор Lawrence, Karl
Автор McLaren-Douglas, Anne
Автор Mitropoulos, Xeni
Автор Mironenko, Tatiana
Автор Thi, Helen
Автор Richardson, Laura
Автор Zhou, Wenjun
Автор Jewitt, Frances
Автор Zhang, Tinghu
Автор Oâ Brien, Patrick
Автор Boisvert, Jessica L.
Автор Price, Stacey
Автор Hur, Wooyoung
Автор Yang, Wanjuan
Автор Deng, Xianming
Автор Butler, Adam
Автор Choi, Hwan Geun
Автор Chang, Jae Won
Автор Baselga, Jose
Автор Stamenkovic, Ivan
Автор Engelman, Jeffrey A.
Автор Sharma, Sreenath V.
Автор Delattre, Olivier
Автор Saez-Rodriguez, Julio
Автор Gray, Nathanael S.
Автор Settleman, Jeffrey
Автор Futreal, P. Andrew
Автор Haber, Daniel A.
Автор Stratton, Michael R.
Автор Ramaswamy, Sridhar
Автор McDermott, Ultan
Автор Benes, Cyril H.
Дата выпуска 2012
dc.description Clinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hundred cancer cell linesâ which represent much of the tissue-type and genetic diversity of human cancersâ with 130 drugs under clinical and preclinical investigation. In aggregate, we found that mutated cancer genes were associated with cellular response to most currently available cancer drugs. Classic oncogene addiction paradigms were modified by additional tissue-specific or expression biomarkers, and some frequently mutated genes were associated with sensitivity to a broad range of therapeutic agents. Unexpected relationships were revealed, including the marked sensitivity of Ewingâ s sarcoma cells harbouring the EWS (also known as EWSR1)-FLI1 gene translocation to poly(ADP-ribose) polymerase (PARP) inhibitors. By linking drug activity to the functional complexity of cancer genomes, systematic pharmacogenomic profiling in cancer cell lines provides a powerful biomarker discovery platform to guide rational cancer therapeutic strategies.
Формат application.pdf
Издатель Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
Копирайт Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
Название Systematic identification of genomic markers of drug sensitivity in cancer cells
Тип ARTICLE
DOI 10.1038/nature11005
Print ISSN 0028-0836
Журнал Nature
Том 483
Первая страница 570
Последняя страница 575
Аффилиация Garnett, Mathew J.; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Edelman, Elena J.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Heidorn, Sonja J.; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Greenman, Chris D.; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Computing, University of East Anglia, Norwich NR4 7TJ, UK (C.D.G.); The Genome Analysis Centre, Norwich Research Park, Norwich NR4 7UH, UK (C.D.G.); Oncology Drug Discovery, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA (S.V.S.).
Аффилиация Dastur, Anahita; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Lau, King Wai; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Greninger, Patricia; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Thompson, I. Richard; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Luo, Xi; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Soares, Jorge; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Liu, Qingsong; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Iorio, Francesco; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; EMBL-EBI, Wellcome Trust Genome Campus, Cambridge CB10 1SD, UK
Аффилиация Surdez, Didier; Laboratoire de génétique et biologie des cancers, Institut Curie, 75248 Paris, Cedex 05, France
Аффилиация Chen, Li; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Milano, Randy J.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Bignell, Graham R.; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Tam, Ah T.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Davies, Helen; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Stevenson, Jesse A.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Barthorpe, Syd; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Lutz, Stephen R.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Kogera, Fiona; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Lawrence, Karl; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация McLaren-Douglas, Anne; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Mitropoulos, Xeni; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Mironenko, Tatiana; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Thi, Helen; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Richardson, Laura; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Zhou, Wenjun; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Jewitt, Frances; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Zhang, Tinghu; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Oâ Brien, Patrick; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Boisvert, Jessica L.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Price, Stacey; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Hur, Wooyoung; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Yang, Wanjuan; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Deng, Xianming; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Butler, Adam; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Choi, Hwan Geun; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Chang, Jae Won; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Baselga, Jose; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Stamenkovic, Ivan; Division of Experimental Pathology, Institute of Pathology, Centre Hospitalier Universitaire Vaudois (CHUV), 1005 Lausanne, Switzerland
Аффилиация Engelman, Jeffrey A.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Sharma, Sreenath V.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA; Department of Computing, University of East Anglia, Norwich NR4 7TJ, UK (C.D.G.); The Genome Analysis Centre, Norwich Research Park, Norwich NR4 7UH, UK (C.D.G.); Oncology Drug Discovery, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA (S.V.S.).
Аффилиация Delattre, Olivier; Laboratoire de génétique et biologie des cancers, Institut Curie, 75248 Paris, Cedex 05, France
Аффилиация Saez-Rodriguez, Julio; EMBL-EBI, Wellcome Trust Genome Campus, Cambridge CB10 1SD, UK
Аффилиация Gray, Nathanael S.; Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston Massachusetts 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
Аффилиация Settleman, Jeffrey; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация Futreal, P. Andrew; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Haber, Daniel A.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA; Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA
Аффилиация Stratton, Michael R.; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Ramaswamy, Sridhar; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Аффилиация McDermott, Ultan; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
Аффилиация Benes, Cyril H.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA
Выпуск 7391

Скрыть метаданые